HomeCLVLF • OTCMKTS
add
Clinuvel Pharmaceuticals Ltd
Previous close
$6.96
Year range
$6.81 - $9.08
Market cap
562.75M AUD
Avg Volume
73.00
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
Market news
Financials
Income Statement
Revenue
Net income
| (AUD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 29.68M | 7.21% |
Operating expense | 12.23M | 58.71% |
Net income | 11.05M | -10.54% |
Net profit margin | 37.22 | -16.55% |
Earnings per share | — | — |
EBITDA | 14.83M | -14.88% |
Effective tax rate | 25.40% | — |
Balance Sheet
Total assets
Total liabilities
| (AUD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 224.11M | 21.88% |
Total assets | 271.75M | 17.58% |
Total liabilities | 30.94M | 10.06% |
Total equity | 240.81M | — |
Shares outstanding | 50.12M | — |
Price to book | 1.45 | — |
Return on assets | 13.56% | — |
Return on capital | 15.27% | — |
Cash Flow
Net change in cash
| (AUD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | 11.05M | -10.54% |
Cash from operations | 13.97M | 161.79% |
Cash from investing | -8.86M | -36.05% |
Cash from financing | 1.81K | 100.39% |
Net change in cash | 5.60M | 409.70% |
Free cash flow | 9.08M | -12.87% |
About
Founded
1987
Website
Employees
16
